Bo Kruse
Director of Finance/CFO bei Y-MABS THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Bo Kruse is currently the CFO, Secretary, Treasurer & Executive VP at Y-mAbs Therapeutics, Inc. He previously worked as the Chief Financial Officer at Genmab A from 2005 to 2008 and as the Chief Financial Officer at Azanta A from 2009 to 2015.
Mr. Kruse also has experience as a Senior Associate at PricewaterhouseCoopers (Denmark).
He holds undergraduate and graduate degrees from Copenhagen Business School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
18.01.2024 | 210 877 ( 0,48% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Bo Kruse
Unternehmen | Position | Beginn |
---|---|---|
Y-MABS THERAPEUTICS, INC. | Director of Finance/CFO | 01.06.2016 |
Ehemalige bekannte Positionen von Bo Kruse
Unternehmen | Position | Ende |
---|---|---|
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Director of Finance/CFO | 01.01.2015 |
GENMAB A/S | Director of Finance/CFO | 02.06.2008 |
PricewaterhouseCoopers (Denmark)
PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a private company based in Hellerup, Denmark. | Corporate Officer/Principal | - |
Ausbildung von Bo Kruse
Copenhagen Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GENMAB A/S | Health Technology |
Y-MABS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
PricewaterhouseCoopers (Denmark)
PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a private company based in Hellerup, Denmark. | Commercial Services |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Health Technology |